299 related articles for article (PubMed ID: 31793218)
1. EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma.
Eladl AE; Shimada K; Suzuki Y; Takahara T; Kato S; Kohno K; Elsayed AA; Wu CC; Tokunaga T; Kinoshita T; Sakata-Yanagimoto M; Nakamura S; Satou A
Cancer Med; 2020 Jan; 9(2):678-688. PubMed ID: 31793218
[TBL] [Abstract][Full Text] [Related]
2. Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group.
Shen Z; Hu L; Yao M; He C; Liu Q; Wang F; Gu W; Wang Y; Dong M; Zhu T; Yin T; Li F; Jin Y; Huang S; Zhang H; Sang W;
Int J Cancer; 2022 Jan; 150(2):327-334. PubMed ID: 34520566
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous angioimmunoblastic T-cell lymphoma: Epstein-Barr virus positivity and its effects on clinicopathologic features.
Lee WJ; Won KH; Choi JW; Won CH; Chang SE; Choi JH; Lee MW
J Am Acad Dermatol; 2019 Oct; 81(4):989-997. PubMed ID: 30240776
[TBL] [Abstract][Full Text] [Related]
4. [Expression and Clinical Pathological Significance of EBER, PTEN and VEGF in Angioimmunoblastic T-Cell Lymphoma].
Wang F; Zhang GH; Ding KY; Liu L; Weng HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):663-8. PubMed ID: 26117013
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH.
Liang JH; Lu L; Zhu HY; Li W; Fan L; Li JY; Xu W
Cancer Res Treat; 2019 Jan; 51(1):150-157. PubMed ID: 29621877
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-infected cells in IgG4-related lymphadenopathy with comparison with extranodal IgG4-related disease.
Takeuchi M; Sato Y; Yasui H; Ozawa H; Ohno K; Takata K; Gion Y; Orita Y; Tachibana T; Itoh T; Asano N; Nakamura S; Swerdlow SH; Yoshino T
Am J Surg Pathol; 2014 Jul; 38(7):946-55. PubMed ID: 24705309
[TBL] [Abstract][Full Text] [Related]
7. Angioimmunoblastic T-cell lymphoma in Taiwan shows a frequent gain of ITK gene.
Liang PI; Chang ST; Lin MY; Hsieh YC; Chu PY; Chen CJ; Lin KJ; Jung YC; Hwang WS; Huang WT; Chang WC; Ye H; Chuang SS
Int J Clin Exp Pathol; 2014; 7(9):6097-107. PubMed ID: 25337257
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO.
d'Amore F; Johansen P; Houmand A; Weisenburger DD; Mortensen LS
Blood; 1996 Feb; 87(3):1045-55. PubMed ID: 8562929
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathological characteristics of C-MYC protein in angioimmunoblastic T-cell lymphoma.
Peng Y; Yan H; Wang J; Zhang M; He J
Acta Biochim Pol; 2022 Jul; 69(3):559-565. PubMed ID: 35878052
[TBL] [Abstract][Full Text] [Related]
10. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.
Yang QX; Pei XJ; Tian XY; Li Y; Li Z
Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus present in T cells or B cells shows differential effects on hemophagocytic symptoms associated with outcome in T-cell lymphomas.
Chen YP; Jones D; Chen TY; Chang KC
Leuk Lymphoma; 2014 Sep; 55(9):2038-47. PubMed ID: 24180328
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus infection, drug resistance and prognosis in Korean T- and NK-cell lymphomas.
Jung CK; Lee KY; Kim Y; Han K; Shim SI; Kim BK; Kang CS
Pathol Int; 2001 May; 51(5):355-63. PubMed ID: 11422793
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of clinicopathological and molecular abnormalities of angioimmunoblastic T-cell lymphoma].
Shi YF; Wang HJ; Liu WP; Mi L; Long MP; Liu YF; Lai YM; Zhou LX; Diao XT; Li XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):521-529. PubMed ID: 37291929
[TBL] [Abstract][Full Text] [Related]
14. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10.
Attygalle A; Al-Jehani R; Diss TC; Munson P; Liu H; Du MQ; Isaacson PG; Dogan A
Blood; 2002 Jan; 99(2):627-33. PubMed ID: 11781247
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological features of angioimmunoblastic T-cell lymphoma pattern Ⅰ].
Lu HD; Xie JL; Zhang LN; Zheng YY; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2022 Sep; 51(9):856-860. PubMed ID: 36097902
[No Abstract] [Full Text] [Related]
16. [Angioimmunoblastic lymphadenopathy and angioimmunoblastic T-cell lymphoma].
Li T; Gao D; Zhang B
Zhonghua Bing Li Xue Za Zhi; 1996 Apr; 25(2):99-101. PubMed ID: 9206215
[TBL] [Abstract][Full Text] [Related]
17. Development of a Novel Clinical Prognostic Model for Patients With Angioimmunoblastic T-Cell Lymphoma.
Huang C; Zhang H; Gao Y; Diao L; Liu L
Technol Cancer Res Treat; 2020; 19():1533033820964231. PubMed ID: 33073702
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma.
Okamoto A; Yanada M; Miura H; Inaguma Y; Tokuda M; Morishima S; Kanie T; Yamamoto Y; Mizuta S; Akatsuka Y; Yoshikawa T; Mizoguchi Y; Nakamura S; Okamoto M; Emi N
Cancer Sci; 2015 Nov; 106(11):1576-81. PubMed ID: 26353084
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus-Induced Cutaneous Diffuse Large B-Cell Lymphoma in a Patient With Angioimmunoblastic T-Cell Lymphoma.
Poon F; Ieremia E; Collins G; Matin RN
Am J Dermatopathol; 2019 Dec; 41(12):927-930. PubMed ID: 31599749
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus load correlating with clinical manifestation and treatment response in a patient with angioimmunoblastic T-cell lymphoma.
Battegay M; Berger C; Rochlitz C; Hurwitz N; Hirsch HH; De Geyter C; Haque T; Nadal D
Antivir Ther; 2004 Jun; 9(3):453-9. PubMed ID: 15259909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
